Shares of CVS Health (CVS) have taken a hit over the past year, and while the company is doing what it can to stem the slide, it hasn't been enough. According to TheStreet's Chris Laudani, the shares appear fairly valued, but there is still a lot of uncertainty surrounding health care in the U.S. right now.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.